The global transcutaneous pacing market is expected to grow at a CAGR of 5.80% between 2023 and 2028, driven by the growing expansion of the healthcare sector across the emerging economies.
Transcutaneous pacing refers to a temporary method of pacing the heart of a patient during an emergency situation. This process involves transmission of electric current through the chest of a patient, leading to heart contraction. It is a readily available remedy which can be used in emergency situations.
Based on type, the market can be segmented into single chamber external pacemaker, dual chamber external pacemaker, and triple chamber external pacemaker. On the basis of application, the market can be classified into bradycardia treatment and tachycardia treatment, among others. By end use, the market has been categorised into hospitals and specialty clinics, among others. The regional markets can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global transcutaneous pacing market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.
The bradycardia treatment segment, based on application, accounts for a significant share in the transcutaneous pacing market. Bradycardia is one of the most prevalent conditions across the world, which leads to a dramatic decline of the rate of heart beat to 60 beats per minute. It can also be caused by complications in heart surgeries and heart tissue damage caused by ageing.
Transcutaneous pacing increases the heartbeat in a record time which boosts the comfort of the patient. The increasing cases of heart-related diseases owing to the rising geriatric population, sedentary lifestyles led by the working population, and lack of sleep, are some of the factors escalating the cases of bradycardia.
At a regional level, North America holds a decent share in the transcutaneous pacing market. The high quality of medical facilities available across the strong economies, such as the United States, is a crucial driving factor of the market. In addition, the increasing prevalence of obesity in the country is leading to an escalation in heart rhythm abnormalities.
Meanwhile, Europe holds a significant share in the market, which is being propelled by the advancements in healthcare infrastructure, increasing elderly population, and improving standards of living. Moreover, the presence of major medical manufacturers in the region are further providing impetus to the market for transcutaneous pacing.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Koninklijke Philips N.V. is a multinational conglomerate company which is headquartered in Amsterdam, Netherlands. It was founded in the year 1891 and has more than 78,000+ employees. Koninklijke Philips N.V. focusses on innovating in the field of health technology. Since its formation, the company has innovated a wide range of medical equipment.
Boston Scientific Corporation is one of the leading manufacturing companies based in the United States. This company manufactures high-end medical equipment which bolsters both the diagnostics and treatment infrastructure across healthcare units. Boston Scientific Corporation has around 40 offices worldwide and approximately 25,000 skilled workers.
Medtronic Plc is a prominent America medical technology company which is headquartered in Dublin, Ireland. The company was founded in 1949 and has a strength of 95,000+ employees. Medtronic Plc offers innovative healthcare solutions across the world. This organisation also focusses on insight-drive care.
Other market players include Biotronik, and OSCOR Inc., among others.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Type||
|Breakup by Application||
|Breakup by End Use||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
7 Industry Opportunities and Challenges
8 Global Transcutaneous Pacing Market Analysis
8.1 Key Industry Highlights
8.2 Global Transcutaneous Pacing Historical Market (2018-2022)
8.3 Global Transcutaneous Pacing Market Forecast (2023-2028)
8.4 Global Transcutaneous Pacing Market by Type
8.4.1 Single Chamber External Pacemaker
22.214.171.124 Market Share
126.96.36.199 Historical Trend (2018-2022)
188.8.131.52 Forecast Trend (2023-2028)
8.4.2 Dual Chamber External Pacemaker
184.108.40.206 Market Share
220.127.116.11 Historical Trend (2018-2022)
18.104.22.168 Forecast Trend (2023-2028)
8.4.3 Triple Chamber External Pacemaker
22.214.171.124 Market Share
126.96.36.199 Historical Trend (2018-2022)
188.8.131.52 Forecast Trend (2023-2028)
8.5 Global Transcutaneous Pacing Market by Application
8.5.1 Bradycardia Treatment
184.108.40.206 Market Share
220.127.116.11 Historical Trend (2018-2022)
18.104.22.168 Forecast Trend (2023-2028)
8.5.2 Tachycardia Treatment
22.214.171.124 Market Share
126.96.36.199 Historical Trend (2018-2022)
188.8.131.52 Forecast Trend (2023-2028)
8.6 Global Transcutaneous Pacing Market by End Use
184.108.40.206 Market Share
220.127.116.11 Historical Trend (2018-2022)
18.104.22.168 Forecast Trend (2023-2028)
8.6.2 Specialty Clinics
22.214.171.124 Market Share
126.96.36.199 Historical Trend (2018-2022)
188.8.131.52 Forecast Trend (2023-2028)
8.7 Global Transcutaneous Pacing Market by Region
8.7.1 Market Share
184.108.40.206 North America
220.127.116.11 Asia Pacific
18.104.22.168 Latin America
22.214.171.124 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
126.96.36.199 United States of America
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
188.8.131.52 United Kingdom
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
184.108.40.206 Saudi Arabia
220.127.116.11 United Arab Emirates
18.104.22.168 South Africa
10 Market Dynamics
10.1 SWOT Analysis
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Koninklijke Philips N.V.
22.214.171.124 Company Overview
126.96.36.199 Product Portfolio
188.8.131.52 Demographic Reach and Achievements
11.2.2 Boston Scientific Corporation
184.108.40.206 Company Overview
220.127.116.11 Product Portfolio
18.104.22.168 Demographic Reach and Achievements
11.2.3 Medtronic Plc
22.214.171.124 Company Overview
126.96.36.199 Product Portfolio
188.8.131.52 Demographic Reach and Achievements
184.108.40.206 Company Overview
220.127.116.11 Product Portfolio
18.104.22.168 Demographic Reach and Achievements
11.2.5 OSCOR Inc.
22.214.171.124 Company Overview
126.96.36.199 Product Portfolio
188.8.131.52 Demographic Reach and Achievements
12 Industry Events and Developments
List of Key Figures and Tables
1. Global Transcutaneous Pacing Market: Key Industry Highlights, 2017 and 2027
2. Global Transcutaneous Pacing Historical Market: Breakup by Type (USD Million), 2018-2022
3. Global Transcutaneous Pacing Market Forecast: Breakup by Type (USD Million), 2023-2028
4. Global Transcutaneous Pacing Historical Market: Breakup by Application (USD Million), 2018-2022
5. Global Transcutaneous Pacing Market Forecast: Breakup by Application (USD Million), 2023-2028
6. Global Transcutaneous Pacing Historical Market: Breakup by End Use (USD Million), 2018-2022
7. Global Transcutaneous Pacing Market Forecast: Breakup by End Use (USD Million), 2023-2028
8. Global Transcutaneous Pacing Historical Market: Breakup by Region (USD Million), 2018-2022
9. Global Transcutaneous Pacing Market Forecast: Breakup by Region (USD Million), 2023-2028
10. North America Transcutaneous Pacing Historical Market: Breakup by Country (USD Million), 2018-2022
11. North America Transcutaneous Pacing Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Europe Transcutaneous Pacing Historical Market: Breakup by Country (USD Million), 2018-2022
13. Europe Transcutaneous Pacing Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Asia Pacific Transcutaneous Pacing Historical Market: Breakup by Country (USD Million), 2018-2022
15. Asia Pacific Transcutaneous Pacing Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Latin America Transcutaneous Pacing Historical Market: Breakup by Country (USD Million), 2018-2022
17. Latin America Transcutaneous Pacing Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Middle East and Africa Transcutaneous Pacing Historical Market: Breakup by Country (USD Million), 2018-2022
19. Middle East and Africa Transcutaneous Pacing Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Global Transcutaneous Pacing Market Structure.
The market is estimated to grow at a CAGR of 5.80% in the forecast period of between 2023 and 2028.
The increasing prevalence of bradycardia and tachycardia, increasing healthcare expenditure across the emerging economies, and rising geriatric population are the major drivers of the market.
The key trends in the market include the growing research and development activities in the healthcare industry, favourable reimbursement policies of governments, and low cost setup for transcutaneous pacing.
Transcutaneous pacing is temporary and placed outside the heart, whereas pacemakers are long-term and implanted into the heart.
Hemodynamically unstable bradycardias and tachycardias require transcutaneous pacing.
A person with a heart rate of 60 beats per minute is considered as low, while a person using transcutaneous pacing has a heart rate of 71-79 beats per minute.
Heart rate of 120-140 with transcutaneous pacing is considered too high.
WiFi or any other signal transmission devices should be kept at least 15 cm away from the transcutaneous pacing equipment.
Koninklijke Philips N.V., Boston Scientific Corporation, Medtronic Plc, Biotronik, and OSCOR Inc., among others, are the key players in the transcutaneous pacing market, according to the report.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.